Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Mutuum Finance (MUTM) has quickly climbed the ranks to become one of the top two tokens priced under $0.05 in July bes ...

LIC's top equity bets show solid fundamentals and steady performance, but fresh upside may be limited. They now offer more ...